Literature DB >> 907337

In vitro activity of cefaclor, a new orally administered cephalosporin antibiotic.

J Santoro, M E Levison.   

Abstract

The in vitro antibacterial activity of cefaclor, cephalothin, and cephalexin against 261 clinical isolates of Staphylococcus aureus and Enterobacteriaceae was compared. Cefaclor and cephalexin were about equally active against S. aureus. Cefaclor was the most active cephalosporin against Escherichia coli, Proteus mirabilis, and Klebsiella pneumoniae. The effect on the antimicrobial activity using a relatively high and low inoculum was pronounced for cefaclor when compared with that of cephalothin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 907337      PMCID: PMC429936          DOI: 10.1128/AAC.12.3.442

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  1 in total

1.  Comparison of in vitro activity of cephalexin, cephradine, and cefaclor.

Authors:  N J Bill; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

  1 in total
  11 in total

1.  Cefaclor: summary of clinical experience.

Authors:  R B Kammer; L J Short
Journal:  Infection       Date:  1979       Impact factor: 3.553

2.  Summary of laboratory studies on the antibacterial activity of cefaclor.

Authors:  D A Preston
Journal:  Infection       Date:  1979       Impact factor: 3.553

3.  Concentration relationships of cefaclor in serum, interstitial fluid, bile, and urine of dogs.

Authors:  N G Waterman; L F Scharfenberger
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

4.  Pharmacokinetics of cefaclor in patients with end stage renal disease and during hemodialysis.

Authors:  S J Berman; W H Boughton; J G Sugihara; E G Wong; M M Sato; A W Siemsen
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

Review 5.  The cephalosporin antibiotics in pediatric therapy.

Authors:  H F Eichenwald; H J Schmitt
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

6.  Pharmacology of cefaclor in normal volunteers and patients with renal failure.

Authors:  J Santoro; B N Agarwal; R Martinelli; N Wenger; M E Levison
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

7.  Susceptibility of Staphylococcus aureus to cefaclor and cephalothin: laboratory and clinical studies.

Authors:  B M Gray; C A Hubbell; H C Dillon
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

8.  Cefaclor versus amoxicillin in the treatment of bacterial pneumonia: a comparative double-blind study.

Authors:  P Leuenberger; S Vrantchev
Journal:  Eur J Clin Microbiol       Date:  1983-02       Impact factor: 3.267

9.  Pharmacological evaluation of cefaclor in volunteers.

Authors:  G R Hodges; C Liu; D R Hinthorn; J L Harms; D L Dworzack
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

10.  [Experience with cefaclor in the treatment of ear, nose and throat infections. Indications for cefaclor therapy (author's transl)].

Authors:  P Federspil; R Bach; C Weich; H J Wilhelm; E Tiesler; W Schätzle
Journal:  Infection       Date:  1979       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.